Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Bain Capital & Hellman & Friedman Acquire athenahealth in $17 Billion Deal
The digital health giant athenahealth, Inc. has found two new investors in a $17 billion acquisition. Affiliates of Hellman & Friedman and Bain Capital are joining up to purchase athenahealth from Evergreen Coast Capital and Veritas Capital, which acquired athenahealth and took it private back in 2019 for $5.7 billion. athenahealth partners with more than 140,000 ambulatory care providers, throughout all 50 states and across more than 120 specialties to help these businesses improve care while also optimizing financial performance. The company’s software suite, including its athenaOne cloud platform, provides physician practice-focused services, such as patient... Read More »
Clearlake-backed nThrive Acquires TransUnion’s Healthcare Business
nThrive, Inc., backed by Clearlake Capital Group, L.P., announced that it has signed a definitive agreement to acquire TransUnion Healthcare, inc., the healthcare data and analytics business of TransUnion, in a $1.75 billion all-cash deal. The acquisition, which is expected to close in the fourth quarter of 2021, will let TransUnion focus on its core businesses of credit, marketing and fraud mitigation solutions. TransUnion Healthcare, a wholly owned subsidiary of TransUnion, provides consumers with online data and analytic services to maximize reimbursement throughout the revenue cycle. The company helps over 1,850 hospitals and 650,000 physicians collectively recover more than $1.2... Read More »
23andMe Merges With Telemedicine Platform Lemonaid Health
On October 22, 23andMe Holdings Co. announced the signing of a definitive merger agreement with Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online, for $400 million. A quarter of the purchase price will be paid in cash and 75% in shares of 23andMe Class A Common Stock. The acquisition, expected to close by the end of 2021, will add Lemonaid Health’s innovative telemedicine and prescription drug delivery services to 23andMe’s consumer business. Headquartered in Sunnyvale, California, 23andMe is a leading consumer genetics and research company that created the world’s largest crowdsourced platform for genetic research. Founded in 2006, the... Read More »
LifeSpeak Acquires Digital Health Company ALAViDA
LifeSpeak Inc. announced the acquisition of ALAViDA Health Ltd., a Vancouver-based digital health company that provides cognitive-behavioral therapy (CBT) health solutions for substance use disorders (SUD), for total consideration of $12 million, comprised of a $7 million cash payment and potential for up to a $5 million earnout. Founded in 2004, LifeSpeak Inc. is a leading software-as-a-service provider of a platform for mental health and total wellbeing education for employees and customer-focused organizations. Lifespeak’s 100% confidential platform is packed with thousands of micro-learning videos, podcasts, “Ask the Expert” chat sessions and tip sheets covering a wide range of topics,... Read More »
Cloudmed Announces Acquisition of Eligibill
On October 14, Cloudmed announced its acquisition of Eligibill, a leading provider of insurance discovery services for hospitals and healthcare systems. The Eligibill acquisition is yet another in a series of investments that have been made by Cloudmed this year. Cloudmed is a healthcare technology company focused on revenue capture and data-driven insights for healthcare providers through its CloudmedAI Platform™. Cloudmed partners with over 3,100 healthcare providers in the United States and recovers over $1.5 billion of underpaid or unidentified revenue for its clients annually. This acquisition grows Cloudmed’s scale in the revenue cycle management (RCM) space, and Eligibill CEO Robert... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
